Clinical trial
A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650
NCT01455896
Study timeline
Study start (actual)2013-03-01Date precision: month
Registry last updated2017-01-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetesunresolved
Interventions
ITCA 650DRUG
ITCA placeboOTHER
Sponsors & collaborators
Intarcia Therapeuticslead sponsor
Mapped research locations
DallasTexas, United States2Las VegasNevada, United States2WichitaKansas, United States2ChicagoIllinois, United States1St LouisMissouri, United States1San AntonioTexas, United States1PittsburghPennsylvania, United States1CincinnatiOhio, United States1San DiegoCalifornia, United States1ColumbusOhio, United States1AustinTexas, United States1Winston-SalemNorth Carolina, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01455896 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.